Navigation Links
Viral Infection Might Trigger High Blood Pressure
Date:5/15/2009

Mouse study shows CMV raises risk of hypertension, hardening of arteries

FRIDAY, May 15 (HealthDay News) -- A hidden viral infection that most adults harbor could be a cause of high blood pressure, animal studies indicate.

Mice infected with cytomegalovirus (CMV) were more likely to develop not only high blood pressure but also the hardening of the arteries called atherosclerosis, according to a report in the May 15 issue of PLoS Pathogens by researchers at Beth Israel Deaconess Hospital in Boston.

"This could be of immense importance," said lead researcher Dr. Clyde Crumpacker, a professor of medicine at Harvard Medical School and an investigator in the Division of Infectious Diseases at Beth Israel Deaconess. "The implication for the human population is that antiviral therapy or a vaccine could be an intervention for high blood pressure."

CMV infection is widespread, Crumpacker noted. Studies indicate that between 60 percent and 99 percent of adults worldwide are infected, according to the study. But aside from pregnancy, where CMV infection is associated with serious birth defects, it causes no problems for most adults "until they get something that compromises the immune system," he noted.

"Vascular [blood vessel] injury has been suspected for quite a while," Crumpacker said. "What we have added, in collaboration with cardiologists, is evidence that in mice, CMV can cause an increase in blood pressure."

Blood vessel problems related to CMV infection were first noted in heart transplant recipients, Crumpacker said. Those who were CMV-positive were more likely to have blockage of the heart arteries.

The new study brought together specialists from several fields, including cardiology, virology and pathology to look at the phenomenon in mice. The study included four groups of mice, two fed a standard diet, and two fed a high-cholesterol diet. After four weeks, mice in one standard-diet group and one high-cholesterol group were infected with CMV.

"We were able to measure blood pressure directly in the arteries of the mice," Crumpacker said. The studies showed increased blood pressure in the infected mice after six weeks, but not in the uninfected group. It also showed that 30 percent of the infected mice in the high-cholesterol group developed atherosclerosis as well as high blood pressure.

There are several possible mechanisms for the pressure-raising effect of CMV, Crumpacker said. One is that it increases the activity of renin, an enzyme associated with high blood pressure. The study showed that CMV also increases activity of angiotensin 11, a protein involved in high blood pressure.

Most cases of high blood pressure in humans are of unknown origin, Crumpacker said. "Ninety-eight percent of the time, we don't know what the cause is," he said. If CMV infection is established as a cause -- something that requires much more research -- the way would be open for better methods of prevention and treatment, Crumpacker said.

"This is very exciting and important work," said Dr. Mark R. Schleiss, who holds the American Legion chair of pediatric infectious disease at the University of Minnesota and is a leading figure in the drive to develop a CMV vaccine.

"It is virtually certain that cytomegalovirus infection makes at least some contribution to cardiovascular disease in people," Schleiss said. "Obviously, cytomegalovirus is not the whole picture. There are other issues, including smoking, physical activity and diet. But this extends our body of knowledge about the role cytomegalovirus infection can play, and it is an important role, in cardiovascular disease."

The effort to develop a CMV vaccine has concentrated on childbirth, since infection during pregnancy is the leading cause of mental retardation and deafness in children, Schleiss said. "Now there is an urgency to develop a vaccine for men as well as women," he said.

More information

The dangers of cytomegalovirus infection are described by the U.S. Centers for Disease Control and Prevention.



SOURCES: Clyde Crumpacker, M.D., professor, medicine, Harvard Medical School, and investigator, Division of Infectious Diseases, Beth Israel Deaconess Hospital, Boston; Mark R. Schleiss, M.D., American Legion chair of pediatric infectious disease, University of Minnesota, Minneapolis; May 15, 2009, PLoS Pathogens


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Veterinarians at high risk for viral, bacterial infections from animals
2. Immune exhaustion driven by antigen in chronic viral infection
3. CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus
4. The Viral Spiral - How A Meme About the Virus May Be More Contagious Than the Virus Itself
5. Using a small stockpile of a secondary antiviral drug in a flu pandemic
6. Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
7. Do patients at risk for B-cell malignancy need antiviral treatment?
8. National Public Health Week Begins Today With Launch of Viral Video Campaign
9. New insights into how brain responds to viral infection
10. Trial Vaccine May Protect Against Serious Viral Infection
11. Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Viral Infection Might Trigger High Blood Pressure
(Date:12/2/2016)... ... , ... On Dec. 2, 2016, CURE® magazine will host the 4th Annual ... MPN Heroes—eight individuals who have made a difference in the field of rare blood ... care, demonstrating leadership within the MPN community and/or a commitment to individual patients. , ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading ... appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective ... , Jason brings extensive financial and operational leadership experience to Advanced Inc. He ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... The annual ... Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who ... C) or prescription drug plan (Part D) need to make changes during this period ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... -- According to the latest market report published ... Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type Segment ... 2024 " the global automated endoscope reprocessors market was valued at US$ 740.6 ... CAGR of 7.2% during an eight-year forecast period 2016-2024, to ... ...
(Date:12/2/2016)... ATLANTA , Dec. 2, 2016 Quantum ... screening and expert radiologist interpretation directly to women at ... partners with corporations, such as Delta Air Lines and ... cancer screening as a component of wellness initiatives. ... women of SunTrust. It enables them to have a ...
(Date:12/2/2016)... On Thursday, December 1st 2016, ... research, development and innovation in the biopharmaceutical industry at ... in the presence of Sergey Tsyb, Vice Minister of ... , Natalia Sanina, First Vice Chairman of the ... of Roszdravnadzor, National Service of Control in Healthcare, Sergey ...
Breaking Medicine Technology: